|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

§
§
* Department of Cell Biology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908; It is not known how membrane fusion proteins that function at neutral pH, for example the human immunodeficiency virus envelope (Env) glycoprotein and intracellular fusion machines, are activated for
target bilayer binding. We have addressed this question
using a soluble oligomeric form of an avian retroviral
Env glycoprotein (API) and soluble forms of its receptor. Binding of soluble receptor to API induces API to
bind to liposomes composed of phosphatidylcholine and cholesterol at neutral pH. Liposome binding only
occurs at fusion permissive temperatures (T > 20°C), is
complete between 2 to 5 min at 37°C, and is stable to
high salt, carbonate, and urea. Liposome binding is mediated by the ectodomain of the transmembrane subunit of API, and a mutant with a Val to Glu substitution in the Env fusion peptide (located in the
ectodomain of the transmembrane subunit) shows significantly reduced liposome binding. Moreover, under
conditions of equivalent binding to API, a mutant receptor that does not support infection (Zingler, K., and
J.A.T. Young. 1996. J. Virol. 70:7510-7516) does not induce significant liposome binding. Our results indicate
that a highly specific interaction between an avian retroviral Env and its receptor activates the retroviral glycoprotein for target bilayer binding at neutral pH in
much the same way as low pH activates the influenza
hemagglutinin. Our findings are discussed in terms of
the mechanisms of viral and cellular fusion proteins
that function at neutral pH.
Department of
Biochemistry and Biophysics, § Howard Hughes Medical Institute, University of California, San Francisco, California 94143; and
Department of Microbiology and Molecular Genetics, Harvard Medical School, Cambridge, Massachusetts 02138
This article has been cited by other articles:
|
|